Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivanus K12

Applied and Environmental Microbiology

Volumn 73, Issue 4, 2007, Pages 1107-1113

  Hyink, Otto ^a   Wescombe, Philip A ^a   Upton, Mathew ^a,b   Ragland, Nancy ^a   Burton, Jeremy P ^a   Tagg, John R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE CLUSTERS; GENETIC LOCI; INHIBITORY STRAINS; LANTIBIOTIC BACTERIOCINS;

BACTERIA; GENETIC ENGINEERING; MICROBIOLOGY; NUCLEIC ACIDS;

GENES;

LANTIBIOTIC; SALIVARICIN A2; SALIVARICIN B; UNCLASSIFIED DRUG;

ANTIBIOTICS; BACTERIUM; GENE; GENETIC ANALYSIS; PLASMID;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; GENE CLUSTER; GENE LOCATION; GENE LOCUS; GENETIC CODE; MEGAPLASMID; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; STREPTOCOCCUS SALIVARIUS; STRUCTURAL GENE;

BACTERIAL PROTEINS; LINKAGE (GENETICS); MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PLASMIDS; STREPTOCOCCUS; TRANSFORMATION, BACTERIAL;

STREPTOCOCCUS; STREPTOCOCCUS SALIVARIUS;

EID: 33847242242     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.02265-06     Document Type: Article

References (29)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Balakrishnan, M., R. S. Simmonds, M. Kilian, and J. R. Tagg. 2002. Different bacteriocin activities of Streptococcus mutatis reflect distinct phylogenetic lineages. J. Med. Microbiol. 51:941-948.
3. Burton, J. P., C. N. Chilcott, C. J. Moore, G. Speiser, and J. R. Tagg. 2006. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J. Appl. Microbiol. 100:754-764.
4. Burton, J. P., P. A. Wescombe, C. J. Moore, C. N. Chilcott, and J. R. Tagg. 2006. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl. Environ. Microbiol. 72:3050-3053.
5. Chatterjee, C., M. Paul, L. Xie, and W. A. van der Donk. 2005. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105:633-684.
6. Dempster, R. P., and J. R. Tagg. 1982. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch. Oral Biol. 27:151-157.
7. Dierksen, K. P., and J. R. Tagg. 2000. The influence of indigenous bacteriocin producing Streptococcus salivarius on the acquisition of Streptococcus pyogenes by primary school children in Dunedin, New Zealand, p. 345-348. In D. R. Martin and J. R. Tagg (ed.), Streptococci and streptococcal diseases: entering the new millennium. Securacopy, Wellington, New Zealand.
8. Gross, E., and J. L. Morell. 1971. The structure of nisin. J. Am. Chem. Soc. 93:4634-4635.
9. Jack, R. W., A. Carne, J. Metzger, S. Stefanovic, H. G. Sahl, G. Jung, and J. Tagg. 1994. Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur. J. Biochem. 220:455-462.
10. Jack, R. W., J. R. Tagg, and B. Ray. 1995. Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59:171-200.
11. Johnson, D. W., J. R. Tagg, and L. W. Wannamaker. 1979. Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J. Med. Microbiol. 12:413-427.
12. Karaya, K., T. Shimizu, and A. Taketo. 2001. New gene cluster for lantibiotic streptin possibly involved in streptolysin S formation. J. Biochem. (Tokyo) 129:769-775.
13. Krull, R. E., P. Chen, J. Novak, M. Kirk, S. Barnes, J. Baker, N. R. Krishna, and P. W. Caufield. 2000. Biochemical structural analysis of the lantibiotic mutacin II. J. Biol. Chem. 275:15845-15850.
14. Kuipers, O. P., M. M. Beerthuyzen, P. G. de Ruyter, E. J. Luesink, and W. M. de Vos. 1995. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270:27299-27304.
15. Piard, J. C., O. P. Kuipers, H. S. Rollema, M. J. Desmazeaud, and W. M. de Vos. 1993. Structure, organization, and expression of the let gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J. Biol. Chem. 268:16361-16368.
16. Ross, K. F., C. W. Ronson, and J. R. Tagg. 1993. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59:2014-2021.
17. Rost, B., and J. Liu. 2003. The PredictProtein server. Nucleic Acids Res. 31:3300-3304.
18. Schnell, N., K. D. Entian, U. Schneider, F. Gotz, H. Zahner, R. Kellner, and G. Jung. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278.
19. Simpson, W. J., N. L. Ragland, C. W. Ronson, and J. R. Tagg. 1995. A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev. Biol. Stand. 85:639-643.
20. Smoot, J. C., K. D. Barbian, J. J. Van Compel, L. M. Smoot, M. S. Chaussee, G. L. Sylva, D. E. Sturdevant, S. M. Ricklefs, S. F. Porcella, L. D. Parkins, S. B. Beres, D. S. Campbell, T. M. Smith, Q. Zhang, V. Kapur, J. A. Daly, L. G. Veasy, and J. M. Musser. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 99:4668-4673.
21. Tagg, J. R., and L. V. Bannister. 1979. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J. Med. Microbiol. 12:397-411.
22. Tagg, J. R., and K. P. Dierksen. 2003. Bacterial replacement therapy: adapting 'germ warfare' to infection prevention. Trends Biotechnol. 21:217-223.
23. Tagg, J. R., and L. G. Vugler. 1986. An inhibitor typing scheme for Streptococcus uberis. J. Dairy Res. 53:451-456.
24. Tagg, J. R., and H. K. Wong. 1983. Inhibitor production by group-G streptococci of human and of animal origin. J. Med. Microbiol. 16:409-415.
25. Upton, M., J. R. Tagg, P. Wescombe, and H. F. Jenkinson. 2001. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J. Bacteriol. 183:3931-3938.
26. van den Hooven, H. W., F. M. Lagerwerf, W. Heerma, J. Haverkamp, J. C. Piard, C. W. Hilbers, R. J. Siezen, O. P. Kuipers, and H. S. Rollema. 1996. The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges. FEES Lett. 391:317-322.
27. Wescombe, P. A., J. P. Burton, P. A. Cadieux, N. A. Klesse, O. Hyink, N. C. K. Heng, C. N. Chilcott, G. Reid, and J. R. Tagg. 2006. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Leeuwenhoek 90:269-280.
28. Wescombe, P. A., and J. R. Tagg. 2003. Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl. Environ. Microbiol. 69:2737-2747.
29. Wescombe, P. A., M. Upton, K. P. Dierksen, N. L. Ragland, S. Sivabalan, R. E. Wirawan, M. A. Inglis, C. J. Moore, G. V. Walker, C. N. Chilcott, H. F. Jenkinson, and J. R. Tagg. 2006. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl. Environ. Microbiol. 72:1459-1466.